For heads of discovery at small biotechs

Experienced hands, scoped to the program

Fractional medicinal chemistry help when you need a senior read on hit assessment, SAR strategy, or lead optimization — sized to the program, not added to headcount.

For investors and boards

Independent chemistry diligence

An outside, experienced read on a portfolio company's discovery plan: the strength of the SAR story, the quality of the chemistry, and how close a program really is to a development candidate.

Track record

Specifics are kept general on purpose — programs, targets, and compounds are not named here.

  • Co-inventor on issued patents in small-molecule discovery programs.
  • First decade: formal hit assessments across multiple projects — from screening through hit declaration.
  • Many subsequent years in lead optimization.
  • One program carried personally from formal hit assessment through candidate selection. The resulting molecule successfully completed Phase 1 and is advancing toward Phase 2.
  • Across the career: multiple programs at various stages of discovery, across multiple therapeutic areas.

What an engagement looks like

Every engagement is shaped around the program in front of us. Common starting points:

Have a program that needs a senior chemistry read?

Tell me a little about where it stands. No program details required to start the conversation.